APTT measurements performed on 362 samples including plasmas from normal subjects, patients receiving LMWH, UFH or DOACs, patients with haemophilia, vWD, or lupus anticoagulant, and plasmas with high levels of HIL also showed excellent agreement. The gene discussed is VWF; the disease is hemophilia.